Earnings Feed
Start Free
Home/Filings/4/0001061983-09-000041
4//SEC Filing

MORGANS DAVID J JR 4

Accession 0001061983-09-000041

CIK 0001061983other
View on SEC.govCompany Profile

Filed

Sep 21, 8:00 PM ET

Accepted

Sep 22, 11:52 AM ET

Size

34.7 KB

Accession

0001061983-09-000041

Insider Transaction Report

Form 4
Period: 2009-09-21
CYTOKINETICS INCCYTK
MORGANS DAVID J JR
EVP-Preclinical R&D
Transactions
  • Sale

    Common Stock

    2009-09-21$4.73/sh−1,400$6,622→ 57,800 total
  • Sale

    Common Stock

    2009-09-21$4.75/sh−400$1,900→ 57,100 total
  • Sale

    Common Stock

    2009-09-21$4.75/sh−500$2,375→ 56,600 total
  • Sale

    Common Stock

    2009-09-21$4.69/sh−300$1,407→ 59,200 total
  • Sale

    Common Stock

    2009-09-21$4.78/sh−100$478→ 54,500 total
  • Sale

    Common Stock

    2009-09-21$4.74/sh−300$1,422→ 57,500 total
  • Sale

    Common Stock

    2009-09-21$4.76/sh−1,200$5,712→ 55,400 total
  • Sale

    Common Stock

    2009-09-21$4.76/sh−300$1,429→ 55,100 total
  • Sale

    Common Stock

    2009-09-21$5.00/sh−2,500$12,500→ 52,000 total
  • Sale

    Common Stock

    2009-09-21$4.77/sh−100$477→ 55,000 total
  • Sale

    Common Stock

    2009-09-21$4.77/sh−400$1,908→ 54,600 total
Holdings

  • Incentive Stock Option (right to buy)

    Exercise: $1.85From: 2009-03-26Exp: 2019-02-26→ Common Stock (43,751 underlying)
    43,751

  • Incentive Stock Option (right to buy)

    Exercise: $6.50From: 2004-04-08Exp: 2014-03-08→ Common Stock (34,000 underlying)
    34,000

  • Incentive Stock Option (right to buy)

    Exercise: $6.59From: 2005-04-11Exp: 2015-04-11→ Common Stock (35,995 underlying)
    35,995

  • Incentive Stock Option (right to buy)

    Exercise: $7.15From: 2006-03-01Exp: 2016-03-01→ Common Stock (15,388 underlying)
    15,388

  • Non-Qualified Stock Option (right to buy)

    Exercise: $6.81From: 2007-04-01Exp: 2017-03-14→ Common Stock (50,190 underlying)
    50,190

  • Non-Qualified Stock Option (right to buy)

    Exercise: $7.15From: 2006-03-01Exp: 2016-03-01→ Common Stock (44,612 underlying)
    44,612

  • Non-Qualified Stock Option (right to buy)

    Exercise: $1.85From: 2009-03-26Exp: 2019-02-26→ Common Stock (106,249 underlying)
    106,249

  • Non-Qualified Stock Option (right to buy)

    Exercise: $3.37From: 2008-03-29Exp: 2018-02-28→ Common Stock (122,286 underlying)
    122,286

  • Non-Qualified Stock Option (right to buy)

    Exercise: $6.59From: 2005-04-11Exp: 2015-04-11→ Common Stock (14,005 underlying)
    14,005

  • Incentive Stock Option (right to buy)

    Exercise: $6.81From: 2007-04-01Exp: 2017-03-14→ Common Stock (14,810 underlying)
    14,810

  • Incentive Stock Option (right to buy)

    Exercise: $3.37From: 2008-03-29Exp: 2018-02-28→ Common Stock (27,714 underlying)
    27,714
Footnotes (7)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 30, 2008.
  • [F2]When the ISO and NQ dated 02/26/2009 are combined for a total grant of 150,000 shares, the option shall vest and become exercisable as to 3,125 shares on 03/26/09 and the balance of 146,875 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/26/13.
  • [F3]When the ISO and NQ dated 02/29/2008 are combined for a total grant of 150,000 shares, the option shall vest and become exercisable as to 3,125 shares on 03/29/08 and the balance of 146,875 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/29/12.
  • [F4]This option shall vest and become exercisable as to 708 shares on 04/08/04 and the balance of 33,292 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/08/08.
  • [F5]When the ISO and NQ dated 04/11/05 are combined for a total grant of 50,000 shares, the option shall vest and become exercisable as to 50,000 shares divided into equal monthly installments such that the option shall be 100% vested on 03/01/2009.
  • [F6]When the ISO and NQ dated 03/14/2007 are combined for a total grant of 65,000 shares, the option shall vest and become exercisable as to 1,354 shares on 04/01/07 and the balance of 63,646 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/01/11.
  • [F7]When the ISO and NQ dated 03/01/2006 are combined for a total grant of 60,000 shares, the option shall vest and become exercisable as to 60,000 shares divided into equal monthly installments such that the option shall be 100% vested on 03/01/2010.

Documents

1 file

Issuer

CYTOKINETICS INC

CIK 0001061983

→
Entity typeother

Related Parties

1
  • filerCIK 0001288528

Filing Metadata

Form type
4
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 11:52 AM ET
Size
34.7 KB
View on SEC.gov